3 Gene Editing Stocks Shaping the Future of Medicine

Vertex Pharmaceuticals (VRTX) Source: Pavel Kapysh / Shutterstock.com Vertex Pharmaceuticals (NASDAQ:VRTX) stands out as one of the most seasoned players in the biotech space. Unlike the sea of start-ups in the gene editing field, Vertex boasts a rich legacy in the pharma space, empowering it to leverage its massive financial resources. In recent years, we've seen it dabbling into new areas like gene editing, targeting inflammatory and autoimmune disorders along with certain cancers. Moreover, it collaborat ...